Sun Y - Search Results

1

Extracellular vesicles in the tumor microenvironment: old stories, but new tales.

Han L, Lam EW, Sun Y. Han L, et al. Among authors: sun y. Mol Cancer. 2019 Mar 30;18(1):59. doi: 10.1186/s12943-019-0980-8. Mol Cancer. 2019. PMID: 30925927 Free PMC article. Review.

2

Second-line pemetrexed versus docetaxel in Chinese patients with locally advanced or metastatic non-small cell lung cancer: a randomized, open-label study.

Sun Y, Wu YL, Zhou CC, Zhang L, Zhang L, Liu XY, Yu SY, Jiang GL, Li K, Qin SK, Ma SL, Han L, Quinlivan M, Orlando M, Zhang XQ. Sun Y, et al. Lung Cancer. 2013 Feb;79(2):143-50. doi: 10.1016/j.lungcan.2012.10.015. Epub 2012 Nov 20. Lung Cancer. 2013. PMID: 23182660 Clinical Trial.

3

SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment.

Sun Y, Zhu D, Chen F, Qian M, Wei H, Chen W, Xu J. Sun Y, et al. Oncogene. 2016 Aug 18;35(33):4321-34. doi: 10.1038/onc.2015.494. Epub 2016 Jan 11. Oncogene. 2016. Retraction in: Oncogene. 2024 Nov 19. doi: 10.1038/s41388-024-03233-8 PMID: 26751775 Free PMC article. Retracted.

4

Extracellular vesicles in the tumor microenvironment: Therapeutic resistance, clinical biomarkers, and targeting strategies.

Han L, Xu J, Xu Q, Zhang B, Lam EW, Sun Y. Han L, et al. Among authors: sun y. Med Res Rev. 2017 Nov;37(6):1318-1349. doi: 10.1002/med.21453. Epub 2017 Jun 6. Med Res Rev. 2017. PMID: 28586517 Free article. Review.

5

Revisiting ovarian cancer microenvironment: a friend or a foe?

Zhang B, Chen F, Xu Q, Han L, Xu J, Gao L, Sun X, Li Y, Li Y, Qian M, Sun Y. Zhang B, et al. Among authors: sun y, sun x. Protein Cell. 2018 Aug;9(8):674-692. doi: 10.1007/s13238-017-0466-7. Epub 2017 Sep 19. Protein Cell. 2018. PMID: 28929459 Free PMC article. Review.

6

The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involving Zscan4 and TAK1.

Zhang B, Fu D, Xu Q, Cong X, Wu C, Zhong X, Ma Y, Lv Z, Chen F, Han L, Qian M, Chin YE, Lam EW, Chiao P, Sun Y. Zhang B, et al. Among authors: sun y. Nat Commun. 2018 Apr 30;9(1):1723. doi: 10.1038/s41467-018-04010-4. Nat Commun. 2018. PMID: 29712904 Free PMC article.

7

Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistance.

Chen F, Long Q, Fu D, Zhu D, Ji Y, Han L, Zhang B, Xu Q, Liu B, Li Y, Wu S, Yang C, Qian M, Xu J, Liu S, Cao L, Chin YE, Lam EW, Coppé JP, Sun Y. Chen F, et al. Among authors: sun y. Nat Commun. 2018 Oct 17;9(1):4315. doi: 10.1038/s41467-018-06860-4. Nat Commun. 2018. PMID: 30333494 Free PMC article.

8

Senescent cells: A new Achilles' heel to exploit for cancer medicine?

Zhang B, Lam EW, Sun Y. Zhang B, et al. Among authors: sun y. Aging Cell. 2019 Feb;18(1):e12875. doi: 10.1111/acel.12875. Epub 2018 Nov 19. Aging Cell. 2019. PMID: 30450821 Free PMC article.

9

Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD-L1)-mediated immunosuppression.

Xu Q, Long Q, Zhu D, Fu D, Zhang B, Han L, Qian M, Guo J, Xu J, Cao L, Chin YE, Coppé JP, Lam EW, Campisi J, Sun Y. Xu Q, et al. Among authors: sun y. Aging Cell. 2019 Dec;18(6):e13027. doi: 10.1111/acel.13027. Epub 2019 Sep 7. Aging Cell. 2019. PMID: 31493351 Free PMC article.

10

Targeting epiregulin in the treatment-damaged tumor microenvironment restrains therapeutic resistance.

Wang C, Long Q, Fu Q, Xu Q, Fu D, Li Y, Gao L, Guo J, Zhang X, Lam EW, Campisi J, Sun Y. Wang C, et al. Among authors: sun y. Oncogene. 2022 Nov;41(45):4941-4959. doi: 10.1038/s41388-022-02476-7. Epub 2022 Oct 6. Oncogene. 2022. PMID: 36202915 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64,574 results

Search Page

Filters